About

This panel will help early-stage researchers identify the regulatory and commercial requirements to support technology development, enabling the prioritization of critical studies to accelerate the transition. Further, the objective will be developing strategies to: identify an investor that matches you and your innovation and its future capabilities, what technology transfer and commercialization VCs look for at relevant stages and identifying an initial business model to get your innovation to market. Another aspect of this panel discussion is to emphasize the need for Basic Biomaterial Science Education to the Regulatory Authority (FDA) and the Payor (CMS). Our continued objective is to assist FDA to Evaluate the Safety & Efficacy, and CMS to provide Commercial Valuation of Medical Devices through an organized Consortium.

Moderator

Subramanian Gunasekaran